JAK inhibitors result in clinically relevant improvement in mental health in RAJanuary 26, 2022Rheumatoid Arthritis
Baricitinib offers pain reduction in RA independent of opioid useJanuary 26, 2022Rheumatoid Arthritis
Filgotinib: A promising option across different patient populations with RAJanuary 26, 2022Rheumatoid Arthritis
Interstitial lung disease is prevalent in patients with RA and tied to shorter survivalJanuary 26, 2022Rheumatoid Arthritis
Immunological response after SARS-CoV-2 vaccine in rituximab-treated RA patientsJanuary 26, 2022Rheumatoid Arthritis
Rheumatology NewsRituximab and COVID-19 vaccines: Studies begin to answer key questionsJanuary 21, 2022COVID-19 UpdatesRheumatoid ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsProactive infliximab monitoring found best for sustaining control of inflammatory diseasesJanuary 10, 2022Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Circulating biomarkers may aid in screening for cardiac alterations in RADecember 25, 2021Rheumatoid Arthritis
